, Tracking Stock Market Picks
Enter Symbol:
Cigna Corporation (CI) [hlAlert]

up 64.01 %

Cigna Corporation (CI) rated Outperform by Leerink Swann

Posted on: Tuesday,  Nov 19, 2013  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Cigna Corporation (NYSE: CI) on 11/19/2013, when the stock price was $84.32. Since
then, Cigna Corporation has gained 64.02% as of 11/30/2015's recent price of $138.30.
If you would have followed this Leerink Swann 's recommendation on CI, you would have gained 64.01% of your investment in 741 days.

CIGNA Corporation is an investor-owned employee benefits organizations in the United States. Its subsidiaries are major providers of health care products and services, group life, accident and disability insurance, retirement products and services and investment management. CIGNA conducts its business through the following operating divisions: Employee Health Care, Life and Disability Benefits; Employee Retirement Benefits and Investment Services; International Life, Health and Employee Benefits; and Other Operations.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/19/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -3.75 %
1 Month down  -1.26 %
3 Months   
1 YTD down  -1.26 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy